Compare Hinge Health Inc. Class A Common Stock (HNGE) vs iShares iBoxx $ Inv Grade Corporate Bond ETF (LQD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs iShares iBoxx $ Inv Grade Corporate Bond ETF — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while iShares iBoxx $ Inv Grade Corporate Bond ETF trades at $103.4 (market cap $29.07B). The key difference: iShares iBoxx $ Inv Grade Corporate Bond ETF is far larger — about 3.4× Hinge Health Inc. Class A Common Stock's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, iShares iBoxx $ Inv Grade Corporate Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and iShares iBoxx $ Inv Grade Corporate Bond ETF for 126 Days on average.
| HNGE | LQD | |
|---|---|---|
Market Cap | $8.48B | $29.07B |
Volume | 879,799 | 26,122,352 |
Sector | Health | Fixed Income |
52-Week High | $105.14 | $112.91 |
52-Week Low | $31.17 | $101.83 |
Typical Hold Time | 0 Days | 126 Days |
Enterprise Value | $8.10B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
LQD trades at $102.55, down slightly by 0.03% on the day, with technical indicators signaling a bearish trend as selling pressure outweighs buying. The ETF faces headwinds from rising bond yields and increased short interest, which grew 53.1% in September. Recent dividends of $0.44-$0.46 provide income support, but the overall market sentiment remains cautious amid a challenging fixed-income environment.
The outlook for LQD is constrained by persistent bond market volatility and higher interest rates, which pressure corporate bond valuations. While the ETF's investment-grade portfolio offers relative safety, further yield increases could limit upside. Key risks include Fed policy uncertainty and economic slowdown concerns, warranting a neutral to cautious stance for equity-focused investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About iShares iBoxx $ Inv Grade Corporate Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index that the advisor believes will help the fund track the underlying index. The underlying index is designed to provide a broad representation of the US dollar-denominated liquid investment-grade corporate bond market.
Read more on LQD →
